Skin Cancer

Kolansky identifies oxybenzone and fragrances as leading causes of sunscreen allergies.

Whitney Hovenic, MD's new SPOOGE sunscreen hopes to engage Gen Z in sun protection, merging skincare with fun and effective sun care strategies.

Discover how the Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center at Mount Sinai leads in innovative skin cancer care and research, celebrating a decade of excellence.

Discover how gene expression profiling transforms melanoma and SCC management, enhancing personalized treatment strategies and improving patient outcomes in skin cancer care.

Castle Biosciences’ DecisionDx-Melanoma test plays a role in melanoma management with precise risk stratification, enhancing patient outcomes and reducing unnecessary surgeries.

Replimune faces FDA challenges for RP1's approval in advanced melanoma, highlighting complexities in cancer drug development and regulatory scrutiny.

This review of the latest dermatologic studies includes insights into ocular safety during laser procedures, radiation dermatitis prevention and management, and more.

At a recent Dermatology Times Case-Based Roundtable event, Gaurav Singh, MD, MPH, FAAD, FACMS, utilized 3 patient cases to explore the role of GEP testing in melanoma and SCC.

This review of the latest dermatologic studies includes insights into immunomodulatory effects of photodynamic therapy for skin cancer, in vivo and ex vivo sonographic evaluation of tumor margins, and more.

Artificial Intelligence (AI) enhances early detection of high-risk cutaneous squamous cell carcinoma (cSCC) by integrating advanced histopathological assessments for improved patient outcomes.

E-learning enhances skin cancer detection by training professionals in optical coherence tomography (OCT) for accurate differentiation between basal cell carcinoma (BCC) and non-BCC lesions.

At a recent Dermatology Times Case-Based Roundtable event, Andrew Baker, PA-C, MBA, explored the management of skin cancers with GEP testing through 4 complex cases.

Discover essential sun protection strategies from Dr. Susan Taylor, focusing on the impacts of UV, visible light, and personalized sunscreen choices.

New research highlights the importance of tinted sunscreens with iron oxides for effective protection against visible light-induced skin pigmentation, especially for darker skin tones.

Explore the latest insights, strategies, and treatments for patients with skin cancer as Dermatology Times looks back on Melanoma and Skin Cancer Awareness Month.

Renata Block, PA-C, speaks with patient advocate Brittanny Groover on her experience, how to educate young patients, and understanding the psychosocial impact of melanoma.

Peter Graylin shares his transformative skin cancer journey, emphasizing the importance of early detection, sun safety, and accessible dermatology programs.

AI Medical Technology launches Dermalyser, an AI tool for melanoma diagnosis, enhancing detection accuracy and skin cancer care in Europe.

As melanoma rates rise, Victor Gall, MD, emphasizes proactive care, early detection, and innovative treatments to improve patient outcomes and survival rates.

New research explores how microgravity and cosmic radiation influence cancer cell behavior, immune responses, and potential advancements in oncology treatments.

The Skin Cancer Foundation's gala raises over $800,000, featuring Christie Brinkley and highlighting vital skin cancer awareness initiatives and personal stories.

Integrating molecular testing into melanoma and SCC management enhances risk assessment and personalizes treatment, revolutionizing patient care in dermatology.

Sun safety awareness grows with Laura Scott, MD, FAAD, and Sun Bum's "Trust the Bum Tour," offering free SPF products and education to diverse communities nationwide.

In honor of Melanoma Awareness Month, Glowbar CEO Rachel Liverman spoke to Dermatology Times about this new collaboration, which aims to increase patients' daily sunscreen use by 2026.

Explore the urgent need for improved skin cancer awareness and care for minority populations, addressing disparities in diagnosis and treatment.

This Melanoma Monday, we take a look at melanoma care in the US, from treatments to persistent gaps in access, early detection, and long-term outcomes.

Patients with mucous membrane pemphigoid face increased skin cancer risks, particularly squamous cell carcinoma, highlighting the need for vigilant screening.

Stage IV melanoma survivors face persistent adverse effects and distress, highlighting the need for targeted psychological support and care.

New findings reveal DecisionDx-Melanoma more accurately identifies patients with under 5% risk of SLN positivity, supporting safer avoidance of SLNB surgery.

The Photobiology Committee also issues a public safety warning regarding sun protection misinformation amid growing rates of skin cancer in the U.S.